Protein expression profiling of normal and neoplastic canine prostate and bladder tissue

Area of Science:

• Veterinary oncology
• Proteomics
• Comparative pathology

Background:

• Canine prostatic carcinoma is a significant cancer in dogs, yet its origin remains unknown, limiting its use as a model for human prostate cancer.
• Understanding the molecular basis of canine prostatic carcinomas is crucial for accurate diagnosis and potential therapeutic strategies.

Purpose of the Study:

• To characterize the proteomic profiles of canine prostatic carcinomas to elucidate their origin.
• To identify differentially expressed proteins in canine prostatic carcinomas compared to normal canine prostate and bladder tissues.

Main Methods:

• Proteomic analysis using two-dimensional differential in-gel electrophoresis (2-D DIGE) on normal canine prostate, normal bladder, and canine prostatic carcinoma tissues.
• Mass spectrometry and protein database homology for protein identification.
• Statistical analysis and principal components analysis (PCA) for data interpretation.

Main Results:

• An average of 230 proteins showed >2.5-fold expression difference in carcinomas versus normal prostate, and 208 proteins versus normal bladder.
• Nine proteins, including alpha-enolase, vimentin, GRP78, endoplasmin (GRP94), albumin, keratins 7 and 8, haptoglobin, and transferrin, were identified as overexpressed.
• Keratin 7, GRP78, and endoplasmin were significantly overexpressed in carcinomas.
• PCA demonstrated that carcinomas formed a distinct cluster separate from normal prostate and bladder tissues.

Conclusions:

• Proteomic analysis successfully segregated canine prostatic carcinomas from normal tissues based on their unique protein expression profiles.
• The study identified specific proteins overexpressed in canine prostatic carcinomas, providing quantitative data for characterizing their origin.
• These findings enhance the understanding of canine prostatic carcinoma and support its utility as a comparative oncology model.